138 related articles for article (PubMed ID: 2339961)
1. Verapamil effect on the accumulation of doxorubicin in the leukemia P388 cells with induced antibiotic resistance.
Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
Arch Geschwulstforsch; 1990; 60(2):129-32. PubMed ID: 2339961
[TBL] [Abstract][Full Text] [Related]
2. [The effect of finoptin on the accumulation of doxorubicin in leukemia P388 cells with induced resistance to the antibiotic].
Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
Biull Eksp Biol Med; 1989 Dec; 108(12):714-6. PubMed ID: 2634447
[TBL] [Abstract][Full Text] [Related]
3. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
[TBL] [Abstract][Full Text] [Related]
4. Effects of Dex-Verapamil on Doxorubicin cytotoxicity in P388 murine leukemia cells.
Noviello E; Allievi E; Russo P; Parodi S
Anticancer Drug Des; 1997 Jun; 12(4):261-76. PubMed ID: 9199659
[TBL] [Abstract][Full Text] [Related]
5. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
Donenko FV; Sitdikova SM; Kabieva AO
Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity to anthracyclines in P388/dx leukaemia cells.
Bossa R; Dasdia T; Galatulas I; Zunino F
Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
[TBL] [Abstract][Full Text] [Related]
7. Exploring multidrug resistance using rhodamine 123.
Kessel D
Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
[TBL] [Abstract][Full Text] [Related]
8. Effects of DMDP, a tiapamil analogue, on adriamycin efflux in adriamycin-resistant and -sensitive P388 cells.
Radel S; Mayhew E; Rustum YM
Anticancer Res; 1987; 7(6):1105-8. PubMed ID: 3442407
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
[TBL] [Abstract][Full Text] [Related]
10. Modulation of doxorubicin resistance in P388/ADR cells by Ro44-5912, a tiapamil derivative.
De Jong G; Gelmon K; Bally M; Goldie J; Mayer L
Anticancer Res; 1995; 15(3):911-6. PubMed ID: 7645981
[TBL] [Abstract][Full Text] [Related]
11. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Nov; 42(11):4730-3. PubMed ID: 7127307
[TBL] [Abstract][Full Text] [Related]
12. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
Ramu A; Cohen L; Glaubiger D
Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
[TBL] [Abstract][Full Text] [Related]
13. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
Nair S; Horton A; Leif RC; Krishan A
Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
[TBL] [Abstract][Full Text] [Related]
14. [Changes in glutathione-S-transferase activity during induction of resistance of leukemia P 388 and Ehrlich ascitic tumor cells to doxorubicin].
Donenko FV; Kabieva AO; Borovkova NB; Moroz LV
Biull Eksp Biol Med; 1991 Aug; 112(8):188-90. PubMed ID: 1786387
[TBL] [Abstract][Full Text] [Related]
15. Modulation of doxorubicin-induced DNA lesions by verapamil, DMDP and dipyridamole in resistant P388 cell lines.
Yin MB; Bankusli I; Frank C; Rustum YM
Anticancer Res; 1990; 10(2A):327-32. PubMed ID: 2346306
[TBL] [Abstract][Full Text] [Related]
16. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
Ganapathi R; Reiter W; Krishan A
J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
Krishan A; Sauerteig A; Gordon K; Swinkin C
Cancer Res; 1986 Apr; 46(4 Pt 1):1768-73. PubMed ID: 3948163
[TBL] [Abstract][Full Text] [Related]
18. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
[TBL] [Abstract][Full Text] [Related]
19. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
[TBL] [Abstract][Full Text] [Related]
20. Modulation of doxorubicin efficacy in P388 leukemia following co-administration of verapamil in mini-osmotic pumps.
Slate DL; Fraser-Smith EB; Rosete JD; Freitas VR; Kim YN; Casey SM
In Vivo; 1993; 7(6A):519-23. PubMed ID: 8193270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
